Thrilled to share a couple of highlights from our Q1 2024 earnings call: ✔️ Hims & Hers increased our outlook for the year, and now expect to achieve $1.2-1.23 billion in revenue and $120-135 million in Adjusted EBITDA in 2024 ✔️ We now have over 1.7M subscribers on the platform, up 41% YoY ✔️ Revenue increased to $278.2 million, up 46% YoY “We are pleased to begin the year with exceptional results and strong momentum throughout the business,” said Andrew Dudum, co-founder and CEO. “Our ability to deliver consistent performance across our key metrics is being fueled by our ability to capitalize on the increasing demand for high-quality, personalized solutions in each of our core specialties. During the period, we added a record number of net new subscribers, increasing 41% versus a year ago and bringing us to 1.7 million subscribers on the Hims & Hers platform. We also delivered our first quarter of double-digit net income profitability. As we continue to expand our offerings and broaden awareness of Hims & Hers as a trusted brand, we expect to continue driving rapid and increasingly profitable growth.” Tap the link to check out the full release. https://lnkd.in/eAj_zjKs #earnings #telehealth #telemedicine
hims & hers
Wellness and Fitness Services
San Francisco, California 109,960 followers
hims & hers offers a modern approach to health and wellness.
About us
Hims & Hers Health, Inc. (better known as Hims & Hers) is a multi-specialty telehealth platform building a virtual front door to the healthcare system. We connect consumers to licensed healthcare professionals, enabling people to access high-quality medical care—from wherever is most convenient—for numerous conditions related to sexual health, hair care, mental health, skincare, primary care, and more. With products and services available across all 50 states and Washington, D.C., Hims & Hers is on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. We normalize health & wellness challenges—and innovate on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so we provide access to personalized care designed for results. At our core, our mission is deeply personal—because we too are customers. In January 2021, the company was listed on the NYSE and is traded under the ticker symbol “HIMS”. To learn more about our brand and offerings, you can visit hims.com and forhers.com.
- Website
-
https://bit.ly/4blaSl2
External link for hims & hers
- Industry
- Wellness and Fitness Services
- Company size
- 501-1,000 employees
- Headquarters
- San Francisco, California
- Type
- Public Company
- Founded
- 2017
Locations
-
Primary
San Francisco, California, US
Employees at hims & hers
Updates
-
#HIRING 🚨 We're looking for a savvy and experienced Senior Data Engineer to join the Data Platform Engineering team! As a Senior Data Engineer, you will work to build a data platform that backs the self-service analytics, machine learning models, and data products serving million+ Hims & Hers subscribers. Learn more about the role: http://spr.ly/60459yeN9 #telehealth #telemedicine #jobopenings #jobopportunity
-
JOB ALERT 🚨 Hims & Hers is looking to hire a Finance Manager, Corporate FP&A to join our finance organization and own reporting weekly, monthly, and quarterly financial forecasts & reporting outcomes. This role is critical to producing accurate financial reporting and driving C-suite strategic decisions. Learn more about the role here: http://spr.ly/6040glAKK #jobopportunity #jobopening #telehealth #telemedicine #hiring
-
Introducing our all-new 𝗦𝗲𝘅 𝗥𝘅 + 𝗖𝗹𝗶𝗺𝗮𝘅 𝗖𝗼𝗻𝘁𝗿𝗼𝗹. 👏 “While our providers have had great success treating erectile dysfunction and premature ejaculation with currently available prescription medications, we believe there is opportunity to continue to improve quality of care and treatment outcomes by offering providers and consumers the ability to access new innovative, personalized treatments,” said Dr. Peter J. Stahl, MD, SVP Men’s Reproductive & Sexual Health, Hims. “Sex Rx + Climax Control will further empower providers on our platform to provide best-in-class care for men with premature ejaculation, both with and without erectile dysfunction.“ Read the full article: http://spr.ly/6040gPYlC
-
#HIRING ALERT 🚨 Hims & Hers is seeking an experienced Sr. Manager, Product Marketing to join the team. The ideal candidate will be a strategic thinker, skilled storyteller, and expert influencer with the demonstrated ability to drive customer-centric strategy across Product Management, Creative, and Growth Marketing teams. Learn more about the role here: http://spr.ly/6044gDc9q #telehealthjobs #telemedicine #jobopening #jopopportunity
-
#HIRING 🚨 We're looking for a savvy and experienced Senior Data Engineer to join the Data Platform Engineering team! As a Senior Data Engineer, you will work with the analytics engineers, product managers, engineers, security, DevOps, analytics, and machine learning teams to build a data platform that backs the self-service analytics, machine learning models, and data products serving Hims & Hers subscribers. Learn more about the role: http://spr.ly/60455q4cd #telehealth #telemedicine #jobopening
-
#HIRING 🚨 Hims & Hers is looking to hire a Financial Analyst to join our team. This role will be responsible for maintaining financial models, driving the monthly forecast process and variance analyses, supporting Monthly Business Reviews, and more. Learn more about the role here: http://spr.ly/60475erv1
-
At Hims & Hers, we believe the compounding of GLP-1 injections can help bring safe and affordable weight loss options to more customers struggling with obesity. Giving confidence and peace of mind to our customers and community is important. That’s why Dr. Patrick Carroll, chief medical officer at Hims & Hers, is sharing the standards we adhere to to ensure our offerings’ safety and quality. Dig in at the link: https://lnkd.in/eNDiNEqn #telemedicine #telehealth #GLP1
-
Dr. Patrick Carroll, chief medical officer at Hims & Hers, spoke at Fortune’s Brainstorm Health conference about our focus on personalization and customer choice in an effort to improve a 'paternalistic' medical system. "Hims & Hers is adapting to the modern patient by publishing content on symptoms that educate people and help bring them into the company’s platform. In this way the company seeks to reach those who use Google or social media as a first resource for medical issues. 'It’s very different than it was even 20 years ago, or even 10 years ago, but that is the model of the future,' Carroll said. 'People are looking for answers online.'" Read the full interview at at the link: http://spr.ly/60495GrUV #telehealth #telemedicine
Hims & Hers’ surprise 85% Wegovy discount is latest step on a journey to make medicine less ‘paternalistic,’ exec says
fortune.com
-
ICYMI: Hims & Hers is now providing access to compounded GLP-1 treatments for eligible customers. "Hims & Hers CEO Andrew Dudum told CNBC that the company is 'confident' that customers will be able to access a consistent supply of the compounded medications. Dudum said Hims & Hers has spent the last year learning about the GLP-1 supply chain and has partnered with one of the largest generic manufacturers in the country that has FDA oversight." Read more: http://spr.ly/6046eAbzg
Shares of Hims & Hers Health surge 27% after startup says it will offer GLP-1 injections
cnbc.com